CH389134A
(de)
|
1960-03-15 |
1965-03-15 |
Ciba Geigy |
Verfahren zur Herstellung neuer Anthrachinonküpenfarbstoffe
|
NL293572A
(pl)
|
1962-06-07 |
|
|
|
CH478816A
(de)
|
1965-10-22 |
1969-09-30 |
Ciba Geigy |
Verfahren zur Herstellung neuer N,N'-Di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanen
|
CH480410A
(de)
|
1967-01-09 |
1969-10-31 |
Geigy Ag J R |
Verfahren zur Herstellung von wasserlöslichen Azopyrimidinfarbstoffen
|
CA961052A
(en)
|
1967-01-12 |
1975-01-14 |
Max Schellenbaum |
N-2-ethylhexyl-n'-aryl ureas and preparation containing them
|
FR1593586A
(pl)
|
1967-10-17 |
1970-06-01 |
|
|
US3608087A
(en)
|
1968-06-21 |
1971-09-21 |
Merck & Co Inc |
Feed compositions
|
US3887329A
(en)
|
1969-05-05 |
1975-06-03 |
Ciba Geigy Ag |
Hexamethyl phosphotriamide-dye compositions
|
BE756953A
(fr)
|
1969-10-02 |
1971-04-01 |
Merck & Co Inc |
Potentialisation d'antibiotiques
|
US3686238A
(en)
|
1970-01-19 |
1972-08-22 |
Syntex Corp |
Glycerol esterified with 2-naphthyl-acetic acids and fatty acids
|
US3852434A
(en)
|
1970-09-11 |
1974-12-03 |
Merck & Co Inc |
Potentiation of ({31 ) cis-1,2-epoxypropyl)phosphonic acid and analogues thereof
|
US3690834A
(en)
|
1971-01-11 |
1972-09-12 |
Syva Co |
Ligand determination with spin labeled compounds by receptor displacement
|
US3966744A
(en)
|
1971-01-11 |
1976-06-29 |
Syva Company |
Spin labeled compounds
|
DE2106585A1
(de)
|
1971-02-11 |
1972-08-24 |
Farbenfabriken Bayer Ag, 5090 Leverkusen |
Aminothiodiazole und Thiodiazol-Azofarbstoffe
|
CH560197A5
(en)
|
1971-05-17 |
1975-03-27 |
Ciba Geigy Ag |
2-alkylthio-4,6-bis (subst amino)-5-nitropyrimidines - - herbicides
|
CH558137A
(de)
|
1971-05-17 |
1975-01-31 |
Ciba Geigy Ag |
Mittel zur beeinflussung des pflanzenwachstums.
|
DE2226703A1
(de)
|
1972-05-25 |
1973-12-13 |
Schering Ag |
Neue tetrahydrocarbazolderivate und verfahren zu ihrer herstellung
|
US3966764A
(en)
|
1972-07-10 |
1976-06-29 |
Syva Company |
Ligand determination of spin labeled compounds by receptor displacement-amphetamine analogs
|
US3849420A
(en)
|
1972-10-20 |
1974-11-19 |
Dow Chemical Co |
Bis-(alkylthio-and alkylsulfonyl)-pentachloroquinolines
|
CH574206A5
(pl)
|
1972-11-16 |
1976-04-15 |
Ciba Geigy Ag |
|
DE2340569C2
(de)
|
1973-08-10 |
1982-12-02 |
Bayer Ag, 5090 Leverkusen |
Azofarbstoffe
|
AT340933B
(de)
|
1973-08-20 |
1978-01-10 |
Thomae Gmbh Dr K |
Verfahren zur herstellung neuer pyrimidinderivate und ihrer saureadditionssalze
|
DE2341925A1
(de)
|
1973-08-20 |
1975-03-06 |
Thomae Gmbh Dr K |
Neue pyrimidinderivate und verfahren zu ihrer herstellung
|
US4057559A
(en)
|
1973-10-01 |
1977-11-08 |
American Home Products Corporation |
Carbazole acetic acid derivatives
|
US4101541A
(en)
|
1973-12-21 |
1978-07-18 |
Ciba-Geigy Corporation |
3-Cyano-1,2,4-thiadiazolyl-5-czo dyestuffs
|
CH584739A5
(pl)
|
1973-12-21 |
1977-02-15 |
Ciba Geigy Ag |
|
FR2258841B1
(pl)
|
1974-01-29 |
1977-11-04 |
Ugine Kuhlmann |
|
AT327605B
(de)
|
1974-05-06 |
1976-02-10 |
Ciba Geigy Ag |
Mittel zur hemmung des pflanzenwachstums
|
AU492126B2
(en)
|
1974-05-14 |
1975-11-20 |
Ciba-Geigy Ag |
Nitropyrimidine derivatives
|
FR2306697A1
(fr)
|
1975-04-10 |
1976-11-05 |
Sogeras |
Nouvelles pyrimidines utilisables comme medicaments antidiabetiques et hypocholesterolemiants
|
US4139705A
(en)
|
1977-05-20 |
1979-02-13 |
The Dow Chemical Company |
Pyrazolopyrimidines
|
US4189579A
(en)
|
1977-05-20 |
1980-02-19 |
The Dow Chemical Company |
Aminoalkylthiopurines
|
DE2731264A1
(de)
|
1977-07-11 |
1979-02-01 |
Boehringer Mannheim Gmbh |
Neue 1-acyl-2-cyanaziridine, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zubereitungen
|
JPS6038696B2
(ja)
|
1977-12-09 |
1985-09-02 |
コニカ株式会社 |
ハロゲン化銀カラ−写真感光材料
|
US4242507A
(en)
|
1978-02-23 |
1980-12-30 |
Fujisawa Pharmaceutical Co., Ltd. |
Sulfonic acid esters
|
DE2831580C2
(de)
|
1978-07-18 |
1980-09-18 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Verfahren und Reagens zur Bestimmung von Glycerin
|
DE2831850A1
(de)
|
1978-07-20 |
1980-02-07 |
Basf Ag |
N-arylsulfonylpyrrole, ihre herstellung und diese enthaltende therapeutische mittel
|
DE2906603A1
(de)
|
1979-02-21 |
1980-09-04 |
Boehringer Mannheim Gmbh |
N-substituierte aziridin-2-carbonsaeurederivate, verfahren zu deren herstellung sowie diese substanzen enthaltende arzneimittel
|
US4343804A
(en)
|
1979-03-26 |
1982-08-10 |
A. H. Robins Company, Inc. |
4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds
|
WO1981003174A1
(en)
|
1980-04-28 |
1981-11-12 |
Teijin Ltd |
Thiazolo(3,2-a)pyrimidine derivatives,process for preparing same,and drug containing same
|
EP0053678A1
(de)
|
1980-12-05 |
1982-06-16 |
BASF Aktiengesellschaft |
5-Amino-1-phenyl-4-cyanpyrazole, diese enthaltende herbizide Mittel, Verfahren zu ihrer Herstellung und ihre Anwendung als Herbizide
|
RU938559C
(ru)
|
1980-12-12 |
1993-11-30 |
Всесоюзный научно-исследовательский химико-фармацевтический институт им.Серго Орджоникидзе |
S-Производные 5-амино-6-меркаптопиримидина, обладающие противоопухолевым и цитостатическим действием
|
DOP1981004033A
(es)
|
1980-12-23 |
1990-12-29 |
Ciba Geigy Ag |
Procedimiento para proteger plantas de cultivo de la accion fitotoxica de herbicidas.
|
US4476248A
(en)
|
1983-02-28 |
1984-10-09 |
The Upjohn Company |
Crystallization of ibuprofen
|
DE3334455A1
(de)
|
1983-03-04 |
1984-09-06 |
Bayer Ag, 5090 Leverkusen |
Guanidin - derivate
|
US4612376A
(en)
|
1983-03-25 |
1986-09-16 |
Fujisawa Pharmaceutical Co., Ltd. |
Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent
|
ZA848275B
(en)
|
1983-12-28 |
1985-08-28 |
Degussa |
New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring
|
DE3406329A1
(de)
|
1984-02-22 |
1985-08-22 |
Merck Patent Gmbh, 6100 Darmstadt |
Pyridone
|
JPS6157587A
(ja)
|
1984-08-29 |
1986-03-24 |
Shionogi & Co Ltd |
縮合複素環誘導体および抗潰瘍剤
|
PH22302A
(en)
|
1985-02-11 |
1988-07-22 |
Fujisawa Pharmaceutical Co |
Piperidine compounds
|
IE860511L
(en)
|
1985-03-01 |
1986-09-01 |
Alfa Farmaceutici Spa |
"Benzoyl urea derivatives having anti-tumor activity"
|
DE3601196A1
(de)
|
1986-01-17 |
1987-07-23 |
Merck Patent Gmbh |
1,4-dihydropyridine
|
US4810699A
(en)
|
1987-02-20 |
1989-03-07 |
American Home Products Corporation |
Substituted 1,3,4,9-tetrahydropyrano[3,4,-b]indole-1-acetic acids, pharmaceutical compositions containing them, and methods for treating inflammatory conditions and for analgesic purposes using them
|
CA1340284C
(en)
|
1987-03-19 |
1998-12-22 |
Zeneca Inc. |
Herbicidal substituted cyclic diones
|
DE68926687T2
(de)
|
1988-01-11 |
1997-03-06 |
Fuji Photo Film Co Ltd |
Verfahren zur Erzeugung von extrem hochkontrastreichen negativen Bildern
|
US4782076A
(en)
|
1988-03-01 |
1988-11-01 |
American Home Products Corporation |
Substituted 2,3,4,9-tetrahydro-1H-carbazole-1-acetic acid derivatives, composition and use
|
PT95692A
(pt)
|
1989-10-27 |
1991-09-13 |
American Home Prod |
Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase
|
NZ238863A
(en)
|
1990-07-19 |
1993-03-26 |
Janssen Pharmaceutica Nv |
Substituted thiazolyl and pyridinyl derivatives
|
US5221678A
(en)
|
1990-07-26 |
1993-06-22 |
Merck Frosst Canada, Inc. |
(quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
|
EP0567643A4
(en)
|
1991-01-16 |
1995-07-19 |
Yoshitomi Pharmaceutical |
PYRIDINE COMPOUND USED AS A SELECTIVE DRUG AND NEW PYRIDINE COMPOUND.
|
CA2070978A1
(en)
|
1991-06-11 |
1992-12-12 |
William J. Greenlee |
Cyclic renin inhibitors
|
GB9114760D0
(en)
|
1991-07-09 |
1991-08-28 |
Pfizer Ltd |
Therapeutic agents
|
JPH0533359A
(ja)
|
1991-08-02 |
1993-02-09 |
Kubota Corp |
全旋回型の小型バツクホウ
|
EP0556889A1
(en)
|
1992-02-18 |
1993-08-25 |
Duphar International Research B.V |
Method of preparing aryl(homo)piperazines
|
DE4208254A1
(de)
|
1992-03-14 |
1993-09-16 |
Hoechst Ag |
Substituierte pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel und fungizid
|
TW237456B
(pl)
|
1992-04-09 |
1995-01-01 |
Ciba Geigy |
|
FR2692575B1
(fr)
|
1992-06-23 |
1995-06-30 |
Sanofi Elf |
Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
NZ314207A
(en)
|
1992-09-28 |
2000-12-22 |
Vertex Pharma |
1-(2-Oxoacetyl)-piperidine-2-carboxylic acid derivatives as multi drug resistant cancer cell sensitizers
|
DE4241632A1
(de)
|
1992-12-10 |
1994-06-16 |
Thomae Gmbh Dr K |
Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
TW370529B
(en)
|
1992-12-17 |
1999-09-21 |
Pfizer |
Pyrazolopyrimidines
|
US5998499A
(en)
|
1994-03-25 |
1999-12-07 |
Dentsply G.M.B.H. |
Liquid crystalline (meth)acrylate compounds, composition and method
|
JPH0753546A
(ja)
|
1993-08-09 |
1995-02-28 |
Kuraray Co Ltd |
ジアリール置換複素環化合物およびその医薬用途
|
EP0723533A1
(en)
|
1993-10-12 |
1996-07-31 |
The Du Pont Merck Pharmaceutical Company |
1n-alkyl-n-arylpyrimidinamines and derivatives thereof
|
GB9400889D0
(en)
|
1994-01-18 |
1994-03-16 |
Sandoz Ltd |
Novel compounds
|
TW574214B
(en)
|
1994-06-08 |
2004-02-01 |
Pfizer |
Corticotropin releasing factor antagonists
|
CN1118454C
(zh)
|
1994-09-09 |
2003-08-20 |
日本新药株式会社 |
杂环衍生物和医药
|
CA2206307A1
(en)
|
1994-11-29 |
1996-06-06 |
Dainippon Pharmaceutical Co., Ltd. |
Indole derivative
|
US5691364A
(en)
|
1995-03-10 |
1997-11-25 |
Berlex Laboratories, Inc. |
Benzamidine derivatives and their use as anti-coagulants
|
DK0813525T3
(da)
|
1995-03-10 |
2004-02-16 |
Berlex Lab |
Benzamidinderivater, deres fremstilling og anvendelse som antikoagulanter
|
IL117659A
(en)
|
1995-04-13 |
2000-12-06 |
Dainippon Pharmaceutical Co |
Substituted 2-phenyl pyrimidino amino acetamide derivative process for preparing the same and a pharmaceutical composition containing same
|
GB9508538D0
(en)
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quinazoline derivatives
|
WO1996033994A1
(fr)
|
1995-04-28 |
1996-10-31 |
Nippon Soda Co., Ltd. |
Derives amino-substitues, leur procede de preparation et herbicide
|
WO1996035689A1
(en)
|
1995-05-12 |
1996-11-14 |
Neurogen Corporation |
Novel deazapurine derivatives; a new class of crf1 specific ligands
|
WO1996036613A1
(fr)
|
1995-05-19 |
1996-11-21 |
Nippon Soda Co., Ltd. |
Derives d'acides benzoiques substitues, procede de production desdits derives et herbicides
|
US6403599B1
(en)
|
1995-11-08 |
2002-06-11 |
Pfizer Inc |
Corticotropin releasing factor antagonists
|
US6956047B1
(en)
|
1995-06-06 |
2005-10-18 |
Pfizer Inc. |
Corticotropin releasing factor antagonists
|
TW438587B
(en)
|
1995-06-20 |
2001-06-07 |
Takeda Chemical Industries Ltd |
A pharmaceutical composition for prophylaxis and treatment of diabetes
|
KR0169813B1
(ko)
|
1995-07-12 |
1999-01-15 |
김종인 |
4-아미노-3-아실나프티리딘 유도체
|
US6248571B1
(en)
|
1995-08-31 |
2001-06-19 |
Lonza Ag |
Method of producing dihydroxypyrimidine derivatives
|
WO1997015549A1
(fr)
|
1995-10-26 |
1997-05-01 |
Tokyo Tanabe Company Limited |
COMPOSES DE PHENYLETHANOLAMINE UTILES EN TANT QUE β3 AGONISTES, LEURS PROCEDE ET INTERMEDIAIRES DE PRODUCTION
|
US5849759A
(en)
|
1995-12-08 |
1998-12-15 |
Berlex Laboratories, Inc. |
Naphthyl-substituted benzimidazole derivatives as anti-coagulants
|
USH2007H1
(en)
|
1996-01-19 |
2001-12-04 |
Fmc Corporation |
Insecticidal N-heterocyclylalkyl-or N-[(polycyclyl)alkyl]-N′substituted piperazines
|
DE19602095A1
(de)
|
1996-01-22 |
1997-07-24 |
Bayer Ag |
Halogenpyrimidine
|
ATE236137T1
(de)
|
1996-02-02 |
2003-04-15 |
Merck & Co Inc |
Heterocyclische verbindungen als antidiabetische mittel und für die behandlung von fettleibigkeit
|
WO1997029109A1
(en)
|
1996-02-07 |
1997-08-14 |
Janssen Pharmaceutica N.V. |
Pyrazolopyrimidines as crf receptor antagonists
|
US5948786A
(en)
|
1996-04-12 |
1999-09-07 |
Sumitomo Pharmaceuticals Company, Limited |
Piperidinylpyrimidine derivatives
|
DE19616486C5
(de)
|
1996-04-25 |
2016-06-30 |
Royalty Pharma Collection Trust |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
DE19624659A1
(de)
|
1996-06-20 |
1998-01-08 |
Klinge Co Chem Pharm Fab |
Neue Pyridylalken- und Pyridylalkinsäureamide
|
AU3176297A
(en)
|
1996-06-25 |
1998-01-14 |
Novartis Ag |
Substituted 7-amino-pyrrolo{3,2-d}pyrimidines and the use thereof
|
US6060478A
(en)
|
1996-07-24 |
2000-05-09 |
Dupont Pharmaceuticals |
Azolo triazines and pyrimidines
|
US5776967A
(en)
|
1996-07-26 |
1998-07-07 |
American Home Products Corporation |
Pyranoindole inhibitors of COX--2
|
AR008789A1
(es)
|
1996-07-31 |
2000-02-23 |
Bayer Corp |
Piridinas y bifenilos substituidos
|
US5830911A
(en)
|
1996-08-14 |
1998-11-03 |
American Home Products Corporation |
Pyranoindole and tetrahydrocarbazole inhibitors of COX-2
|
TW477787B
(en)
|
1996-08-27 |
2002-03-01 |
Pfizer |
Pyrido six-membered nitrogen-containing cyclic ring derivatives having corticotropin releasing factor antagonist activity and pharmaceutical composition containing same
|
WO1998008847A1
(en)
|
1996-08-28 |
1998-03-05 |
Pfizer Inc. |
Substituted 6,5-hetero-bicyclic derivatives
|
IL128691A
(en)
|
1996-09-12 |
2007-07-24 |
Bayer Schering Pharma Ag |
History of enzamidine converted by annular amino acid and history of annular hydroxy acid and their use against coagulation
|
US6008234A
(en)
|
1996-09-12 |
1999-12-28 |
Berlex Laboratories, Inc. |
Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants
|
GB9718972D0
(en)
|
1996-09-25 |
1997-11-12 |
Zeneca Ltd |
Chemical compounds
|
TW492957B
(en)
|
1996-11-07 |
2002-07-01 |
Novartis Ag |
N-substituted 2-cyanopyrrolidnes
|
DZ2376A1
(fr)
|
1996-12-19 |
2002-12-28 |
Smithkline Beecham Plc |
Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
|
NO980546L
(no)
|
1997-02-11 |
1998-08-12 |
Lilly Co Eli |
Farmas°ytiske midler
|
EP0970082A2
(en)
|
1997-02-18 |
2000-01-12 |
Neurocrine Biosciences, Inc. |
Biazacyclic crf antagonists
|
DE69818248T2
(de)
|
1997-04-22 |
2004-06-17 |
Janssen Pharmaceutica N.V. |
Chinolin- und chinazolin-derivate als crf antagonisten
|
US6211195B1
(en)
|
1997-04-22 |
2001-04-03 |
Neurocrine Biosciences, Inc. |
CRF antagonistic thiophenopyridines
|
JPH11193277A
(ja)
|
1997-05-14 |
1999-07-21 |
Nippon Soda Co Ltd |
ピリミジン誘導体、その製法および有害生物防除剤
|
AU9256898A
(en)
|
1997-08-14 |
1999-03-08 |
Bayer Aktiengesellschaft |
Methoximinomethyloxadiazines used as pesticides
|
DE19737723A1
(de)
|
1997-08-14 |
1999-02-18 |
Bayer Ag |
Methoximinomethyloxadiazine
|
NL1010018C2
(nl)
|
1997-09-09 |
1999-03-10 |
Duphar Int Res |
Chinoline en chinazoline derivaten met corticotropine releasing factor (CRF) antagonistische werking.
|
US6861448B2
(en)
|
1998-01-14 |
2005-03-01 |
Virtual Drug Development, Inc. |
NAD synthetase inhibitors and uses thereof
|
US6187777B1
(en)
|
1998-02-06 |
2001-02-13 |
Amgen Inc. |
Compounds and methods which modulate feeding behavior and related diseases
|
CA2326383A1
(en)
|
1998-04-02 |
1999-10-14 |
Neurogen Corporation |
Aminoalkyl substituted pyrrolo[2,3-b]pyridine and pyrrolo[2,3-d]pyrimidine derivatives: modulators of crf1 receptors
|
JP2000038350A
(ja)
|
1998-05-18 |
2000-02-08 |
Yoshitomi Pharmaceut Ind Ltd |
糖尿病治療薬
|
CA2339188A1
(en)
|
1998-08-21 |
2000-03-02 |
Dupont Pharmaceuticals Company |
Isoxazolo¬4,5-d|pyrimidines as crf antagonists
|
AP1683A
(en)
|
1998-11-10 |
2006-11-29 |
Janssen Pharmaceutica Nv |
HIV replication inhibiting pyrimidines.
|
US6262088B1
(en)
|
1998-11-19 |
2001-07-17 |
Berlex Laboratories, Inc. |
Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
|
ES2308759T3
(es)
|
1998-11-20 |
2008-12-01 |
Arena Pharmaceuticals, Inc. |
Receptores acoplados a proteina g humanos huerfanos.
|
CO5150173A1
(es)
|
1998-12-10 |
2002-04-29 |
Novartis Ag |
Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
|
US6239126B1
(en)
|
1998-12-17 |
2001-05-29 |
American Home Products Corporation |
Arylpiperidine and aryl-1,2,5,6-tetra-hydropyridine urea derivatives
|
CN1335835A
(zh)
|
1998-12-17 |
2002-02-13 |
美国家用产品公司 |
具有5ht1a受体活性的芳基哌啶和芳基-1,2,5,6-四氢吡啶脲衍生物
|
EA200100675A1
(ru)
|
1998-12-18 |
2001-12-24 |
Аксис Фармасьютикалз, Инк. |
Ингибиторы протеазы
|
CZ27399A3
(cs)
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
CZ300293B6
(cs)
|
1999-03-17 |
2009-04-15 |
Astrazeneca Ab |
Nové amidové deriváty, zpusob jejich prípravy a farmaceutická kompozice, která je obsahuje
|
EP1040831A3
(en)
|
1999-04-02 |
2003-05-02 |
Pfizer Products Inc. |
Use of corticotropin releasing factor (CRF) antagonists to prevent sudden death
|
IL145922A0
(en)
|
1999-04-28 |
2002-07-25 |
Aventis Pharma Gmbh |
Di-aryl acid derivatives as ppar receptor ligands
|
WO2001003739A1
(fr)
|
1999-07-12 |
2001-01-18 |
Ono Pharmaceutical Co., Ltd. |
Inhibiteurs de fibrose contenant comme ingredient actif l'agoniste du recepteur de sphingosine-1-phosphate ou la sphingosine-1-phosphate
|
EP1074549B1
(en)
|
1999-08-06 |
2003-11-19 |
F. Hoffmann-La Roche Ag |
Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors
|
US6921763B2
(en)
|
1999-09-17 |
2005-07-26 |
Abbott Laboratories |
Pyrazolopyrimidines as therapeutic agents
|
CZ2002936A3
(cs)
|
1999-09-17 |
2002-10-16 |
Abbott Gmbh & Co. Kg |
Pyrazolopyrimidiny jako terapeutické prostředky
|
JP2001089452A
(ja)
|
1999-09-22 |
2001-04-03 |
Sankyo Co Ltd |
ピリミジン誘導体
|
US6414002B1
(en)
|
1999-09-22 |
2002-07-02 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
UA74797C2
(uk)
|
1999-09-24 |
2006-02-15 |
Янссен Фармацевтика Н.В. |
Антивірусна композиція
|
US6372743B1
(en)
|
1999-09-30 |
2002-04-16 |
Neurogen Corporation |
Certain alkylene diamine-substituted pyrazlo (1,5-a)-1,5-pyrimidines and pyrazolo (1,5-a) 1,3,5-triazines
|
AU7737900A
(en)
|
1999-09-30 |
2001-04-30 |
Neurogen Corporation |
Amino substituted pyrazolo(1,5,-a)-1,5-pyrimidines and pyrazolo(1,5-a)-1,3,5-triazines
|
CN1377356A
(zh)
|
1999-09-30 |
2002-10-30 |
纽罗杰有限公司 |
亚烷基二胺取代的杂环
|
DE19947154A1
(de)
|
1999-10-01 |
2001-10-04 |
Bayer Ag |
Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
|
US6887870B1
(en)
|
1999-10-12 |
2005-05-03 |
Bristol-Myers Squibb Company |
Heterocyclic sodium/proton exchange inhibitors and method
|
IL139197A0
(en)
|
1999-10-29 |
2001-11-25 |
Pfizer Prod Inc |
Use of corticotropin releasing factor antagonists and related compositions
|
GR990100388A
(el)
|
1999-11-09 |
2001-07-31 |
|
Φαρμακευτικος συνδυασμος αποτελουμενος απο χωριστες δοσολογικες μορφες σε συσκευασια συμμορφωσης (compliance package) ενος αναστολεα της αναγωγασης του υδροξυ-μεθυλο-γλουταρυλο συνενζυμου α (στατινης, statin) και ενος παραγωγου του φιμπρικου οξεος....
|
JP2003518128A
(ja)
|
1999-12-22 |
2003-06-03 |
メルク フロスト カナダ アンド カンパニー |
タンパク質チロシンホスファターゼ1b(ptp−1b)のインヒビターとなる芳香族ホスホネート
|
DE19962936A1
(de)
|
1999-12-24 |
2001-06-28 |
Bayer Ag |
Neue beta-Aminosäureverbindungen als Integrinantagonisten
|
DE60009154D1
(de)
|
1999-12-30 |
2004-04-22 |
Lundbeck & Co As H |
Phenylpiperazinyl-derivate
|
KR20020063934A
(ko)
|
2000-01-18 |
2002-08-07 |
화이자 프로덕츠 인코포레이티드 |
코르티코트로핀 방출 인자 길항제
|
MXPA02007525A
(es)
|
2000-02-09 |
2002-12-13 |
Hokuriku Pharmaceutical |
Derivados 1h-imidazopiridina..
|
AU2001236948A1
(en)
|
2000-02-15 |
2001-08-27 |
Foster-Miller Inc. |
No voc radiation curable resin compositions
|
EP1259494A4
(en)
|
2000-02-18 |
2004-09-15 |
Merck & Co Inc |
ARYLOXY ACETIC ACIDS FOR DIABETES AND LIPID DISEASES
|
US6569879B2
(en)
|
2000-02-18 |
2003-05-27 |
Merck & Co., Inc. |
Aryloxyacetic acids for diabetes and lipid disorders
|
EP1261327B1
(en)
|
2000-02-25 |
2005-04-27 |
F.Hoffmann-La Roche Ag |
Adenosine receptor modulators
|
PE20020229A1
(es)
|
2000-04-12 |
2002-04-11 |
Novartis Ag |
COMBINACION DE UN ANTAGONISTA DEL RECEPTOR AT1; UN INHBIDOR DE HMG-CoA REDUCTASA Y UN INHIBIDOR DE ACE
|
JP4969010B2
(ja)
|
2000-05-08 |
2012-07-04 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Hiv複製阻害性ピリミジンのプロドラッグ
|
DE10024319A1
(de)
|
2000-05-17 |
2001-11-22 |
Merck Patent Gmbh |
Bisacylguanidine
|
AU6744501A
(en)
|
2000-05-18 |
2001-11-26 |
Bayer Aktiengesellschaft |
Regulation of human dopamine-like g protein-coupled receptor
|
WO2001087892A1
(en)
|
2000-05-18 |
2001-11-22 |
Neurocrine Biosciences, Inc. |
Crf receptor antagonists
|
ATE280162T1
(de)
|
2000-05-25 |
2004-11-15 |
Hoffmann La Roche |
Substituierte 1-aminoalkyl-lactame und ihre verwendung als muscarinrezeptor antagonisten
|
US6620821B2
(en)
|
2000-06-15 |
2003-09-16 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
KR20030017569A
(ko)
|
2000-06-28 |
2003-03-03 |
테바 파마슈티컬 인더스트리즈 리미티드 |
카르베딜올
|
AU2001268718B2
(en)
|
2000-06-29 |
2006-01-05 |
Abbott Laboratories |
Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
|
AR028782A1
(es)
|
2000-07-05 |
2003-05-21 |
Taisho Pharmaceutical Co Ltd |
Derivados heterociclicos tetrahidropiridino o piperidino
|
US6444685B1
(en)
|
2000-07-17 |
2002-09-03 |
Wyeth |
N-(4-sulfonylaryl)Cyclylamine 2-hydroxyethylamines as beta-3 adrenergic receptor agonists
|
KR20030026979A
(ko)
|
2000-07-18 |
2003-04-03 |
야마노우치세이야쿠 가부시키가이샤 |
디시아노피리딘 유도체를 포함하는 의약
|
US6410583B1
(en)
|
2000-07-25 |
2002-06-25 |
Merck Frosst Canada & Co. |
Cyclopentanoindoles, compositions containing such compounds and methods of treatment
|
AU7705601A
(en)
|
2000-07-25 |
2002-02-05 |
Merck & Co Inc |
N-substituted indoles useful in the treatment of diabetes
|
AU2001284417A1
(en)
|
2000-09-05 |
2002-03-22 |
Taisho Pharmaceutical Co. Ltd. |
Hair growth stimulants
|
EP1322289B1
(en)
|
2000-09-20 |
2007-07-25 |
Jagotec AG |
Spray drying process of compositions containing fenofibrate
|
US7276249B2
(en)
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US20030224058A1
(en)
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
PE20020507A1
(es)
|
2000-10-17 |
2002-06-25 |
Schering Corp |
Compuestos no-imidazoles como antagonistas del receptor histamina h3
|
WO2002032408A2
(en)
|
2000-10-20 |
2002-04-25 |
Novartis Ag |
Combinations of a thyromimetic compound and a statin
|
ES2372028T3
(es)
|
2000-10-23 |
2012-01-13 |
Glaxosmithkline Llc |
Nuevo compuesto de 8h-pirido[2,3-d]pirimidin-7-ona trisustituida para el tratamiento de enfermedades mediadas por la csbp/p38 quinasa.
|
CA2427610A1
(en)
|
2000-10-31 |
2002-08-08 |
Merck & Co., Inc. |
Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
|
ES2279835T3
(es)
|
2000-11-03 |
2007-09-01 |
Neurocrine Biosciences, Inc. |
Antagonistas del receptor de crf y metodos relacionados.
|
US20020058026A1
(en)
|
2000-11-13 |
2002-05-16 |
Milton Hammerly |
HMG CoA reductase inhibitor medications combined wih CoEnzyme Q-10
|
WO2002039987A2
(en)
|
2000-11-14 |
2002-05-23 |
Neurosearch A/S |
Use of malaria parasite anion channel blockers for treating malaria
|
UA77165C2
(en)
|
2000-11-17 |
2006-11-15 |
Lilly Co Eli |
(n)-((s)-2-hydroxy-3-methyl-butyryl)-1-(l-alaninyl)-(s)-1-amino-3-methyl-4,5,6,7-tetrahydro-2h-3-benzazepin-2-one dihydrate, processes for manufacturing and pharmaceutical composition
|
WO2002040458A1
(fr)
|
2000-11-17 |
2002-05-23 |
Takeda Chemical Industries, Ltd. |
Derives d'isoxazole
|
EP1335907B1
(en)
|
2000-11-20 |
2010-06-09 |
Biovitrum AB (publ) |
Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor
|
JP3438186B2
(ja)
|
2000-12-01 |
2003-08-18 |
山之内製薬株式会社 |
糖尿病治療剤スクリーニング方法
|
US20020137755A1
(en)
|
2000-12-04 |
2002-09-26 |
Bilodeau Mark T. |
Tyrosine kinase inhibitors
|
US6545017B1
(en)
|
2000-12-08 |
2003-04-08 |
3M Innovative Properties Company |
Urea substituted imidazopyridines
|
US20020107262A1
(en)
|
2000-12-08 |
2002-08-08 |
3M Innovative Properties Company |
Substituted imidazopyridines
|
US6525064B1
(en)
|
2000-12-08 |
2003-02-25 |
3M Innovative Properties Company |
Sulfonamido substituted imidazopyridines
|
US6545016B1
(en)
|
2000-12-08 |
2003-04-08 |
3M Innovative Properties Company |
Amide substituted imidazopyridines
|
AU2002231139B2
(en)
|
2000-12-21 |
2007-03-22 |
Bristol-Myers Squibb Company |
Thiazolyl inhibitors of tec family tyrosine kinases
|
RU2756946C2
(ru)
|
2001-01-26 |
2021-10-07 |
Мерк Шарп И Доум Корп. |
Применение замещенных азетидинонов для лечения ситостеролемии
|
AU2002240235B2
(en)
|
2001-01-30 |
2006-07-06 |
Merck & Co., Inc. |
Acyl sulfamides for treatment of obesity, diabetes and lipid disorders
|
AU2002237988B2
(en)
|
2001-01-30 |
2008-01-03 |
University Of Virginia Patent Foundation |
Agonists and antagonists of sphingosine-1-phosphate receptors
|
BR0207302A
(pt)
|
2001-02-08 |
2004-02-10 |
Memory Pharm Corp |
Trifluorometilpurinas como inibidores da fosfodiesterase 4
|
EP1366012A4
(en)
|
2001-02-09 |
2005-11-02 |
Merck & Co Inc |
2-ARYLOXY-2-ARYLALCANO ACIDS AS USED FOR THE TREATMENT OF DIAB TES AND LIPID DISORDERS
|
DE10110754A1
(de)
|
2001-03-07 |
2002-09-19 |
Bayer Ag |
Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
|
WO2002072101A1
(en)
|
2001-03-13 |
2002-09-19 |
Bristol-Myers Squibb Pharma Company |
A corticotropin releasing factor receptor ligand, its enantiomer and pharmaceutically acceptable salts
|
EP1375463A4
(en)
|
2001-03-29 |
2009-09-02 |
Osaka Gas Co Ltd |
OPTICALLY ACTIVE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION
|
WO2002081454A1
(en)
|
2001-04-09 |
2002-10-17 |
Dr. Reddy's Laboratories Ltd. |
Derivatives of aryl acids, their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
AR035235A1
(es)
|
2001-04-20 |
2004-05-05 |
Wyeth Corp |
Derivados heterocicliloxi-,-tioxi- y -aminobenzazol como ligandos de 5-hidroxitriptamina-6, un procedimiento para su preparacion, composicion farmaceutica, y el uso de dichos derivados para la manufactura de un medicamento
|
KR20030096354A
(ko)
|
2001-05-10 |
2003-12-24 |
오노 야꾸힝 고교 가부시키가이샤 |
카르복실산 유도체 화합물 및 이를 유효 성분으로 하는 약제
|
DE60234338D1
(de)
|
2001-06-01 |
2009-12-24 |
Hoffmann La Roche |
Pyrimidin, triazin und pyrazinderivate als glutamatrezeptoren
|
WO2002102313A2
(en)
|
2001-06-19 |
2002-12-27 |
Bristol-Myers Squibb Company |
Pyrimidine inhibitors of phosphodiesterase (pde) 7
|
US6825198B2
(en)
|
2001-06-21 |
2004-11-30 |
Pfizer Inc |
5-HT receptor ligands and uses thereof
|
CA2451128A1
(en)
|
2001-06-26 |
2003-01-09 |
Bristol-Myers Squibb Company |
N-heterocyclic inhibitors of tnf-alpha expression
|
UA74912C2
(en)
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
GB0117899D0
(en)
|
2001-07-23 |
2001-09-12 |
Astrazeneca Ab |
Chemical compounds
|
JPWO2003026661A1
(ja)
|
2001-09-14 |
2005-01-06 |
山之内製薬株式会社 |
インスリン分泌促進剤及び新規なピリミジン誘導体
|
CA2461212C
(en)
|
2001-09-27 |
2010-08-17 |
Kyorin Pharmaceutical Co., Ltd. |
Diaryl sulfide derivatives, salts thereof and immunosuppressive agents using the same
|
US6825184B2
(en)
|
2001-10-18 |
2004-11-30 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
1,4-Disubstituted benzo-fused urea compounds
|
SE0104334D0
(sv)
|
2001-12-19 |
2001-12-19 |
Astrazeneca Ab |
Therapeutic agents
|
GB0229931D0
(en)
|
2002-12-21 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
EP1461069A2
(en)
|
2001-12-29 |
2004-09-29 |
Novo Nordisk A/S |
Combined use of a glp-1 compound and another drug for treating dyslipidemia
|
US20050043315A1
(en)
|
2002-01-02 |
2005-02-24 |
Hideo Tsutsumi |
Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them
|
US20070225351A1
(en)
|
2002-01-11 |
2007-09-27 |
Lippa Arnold S |
Methods and compositions for controlling body weight and appetite
|
US20050239899A1
(en)
|
2002-01-18 |
2005-10-27 |
Wolfgang Fecke |
Beta-secretase inhibitors
|
WO2003061567A2
(en)
|
2002-01-18 |
2003-07-31 |
Merck & Co., Inc. |
Selective s1p1/edg1 receptor agonists
|
DE60329073D1
(de)
|
2002-01-18 |
2009-10-15 |
Merck & Co Inc |
Edg-rezeptoragonisten
|
GB0201850D0
(en)
|
2002-01-26 |
2002-03-13 |
Astrazeneca Ab |
Therapeutic treatment
|
WO2003073986A2
(en)
|
2002-03-01 |
2003-09-12 |
Merck & Co., Inc. |
Aminoalkylphosphonates and related compounds as edg receptor agonists
|
EP1482896A4
(en)
|
2002-03-01 |
2005-11-23 |
Merck & Co Inc |
AMINOALKYLPHOSPHONATES AND ASSOCIATED COMPOUNDS AS EDG RECEPTOR AGONISTS
|
DE60336901D1
(de)
|
2002-03-07 |
2011-06-09 |
X Ceptor Therapeutics Inc |
Chinazolinon modulatoren von nukleinrezeptoren
|
EP1484971B1
(en)
|
2002-03-15 |
2007-07-04 |
Ciba SC Holding AG |
Use of 4-aminopyrimidines for the antimicrobial treatment of surfaces
|
AR039090A1
(es)
|
2002-03-22 |
2005-02-09 |
Novartis Ag |
Combinacion de compuestos organicos
|
WO2003088962A1
(en)
|
2002-04-16 |
2003-10-30 |
Merck & Co., Inc. |
Combination therapy using a ppar alpha/gamma agonist
|
AU2003222786A1
(en)
|
2002-04-18 |
2003-10-27 |
Ucb, S.A. |
Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions
|
DE10219435A1
(de)
|
2002-05-02 |
2003-11-13 |
Bayer Cropscience Ag |
Substituierte Pyrazolo-pyrimidin-4-one
|
AU2003225305A1
(en)
|
2002-05-08 |
2003-11-11 |
Bristol-Myers Squibb Company |
Pyridine-based thyroid receptor ligands
|
US7057046B2
(en)
|
2002-05-20 |
2006-06-06 |
Bristol-Myers Squibb Company |
Lactam glycogen phosphorylase inhibitors and method of use
|
AU2003241478A1
(en)
|
2002-06-10 |
2003-12-22 |
Elan Pharma International, Ltd. |
Nanoparticulate sterol formulations and sterol combinations
|
WO2003103632A1
(en)
|
2002-06-10 |
2003-12-18 |
Elan Pharma International, Ltd. |
Nanoparticulate polycosanol formulations and novel polycosanol combinations
|
AR040241A1
(es)
|
2002-06-10 |
2005-03-23 |
Merck & Co Inc |
Inhibidores de la 11-beta-hidroxiesteroide deshidrogrenasa 1 para el tratamiento de la diabetes obesidad y dislipidemia
|
EP1531799A1
(en)
|
2002-06-10 |
2005-05-25 |
Elan Pharma International Limited |
Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives ("statins"), novel combinations thereof as well as manufacturing of these pharmaceutical compositions
|
DE60335639D1
(de)
|
2002-06-14 |
2011-02-17 |
Amylin Pharmaceuticals Inc |
Prävention und/oder behandlung von colitis ulcerosa mit pyy oder pyyä3-36ü
|
AU2003276043A1
(en)
|
2002-06-17 |
2003-12-31 |
Merck & Co., Inc. |
1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists
|
DE10226943A1
(de)
|
2002-06-17 |
2004-01-08 |
Bayer Ag |
Phenylaminopyrimidine und ihre Verwendung
|
GB0214254D0
(en)
|
2002-06-20 |
2002-07-31 |
Glaxo Group Ltd |
Chemical compounds
|
SE0201980D0
(sv)
|
2002-06-24 |
2002-06-24 |
Astrazeneca Ab |
Novel compounds
|
SE0201976D0
(sv)
|
2002-06-24 |
2002-06-24 |
Astrazeneca Ab |
Novel compounds
|
JP5219329B2
(ja)
|
2002-06-28 |
2013-06-26 |
ネステク、リミテッド |
下痢の予防又は治療用の医薬組成物
|
US7071210B2
(en)
|
2002-07-02 |
2006-07-04 |
Pfizer Inc. |
CETP inhibitors in combination with antihypertensive agents and uses thereof
|
US20040053842A1
(en)
|
2002-07-02 |
2004-03-18 |
Pfizer Inc. |
Methods of treatment with CETP inhibitors and antihypertensive agents
|
US20060004010A1
(en)
|
2002-07-10 |
2006-01-05 |
Hiromu Habashita |
Ccr4 antagonist and medical use thereof
|
WO2004009597A2
(en)
|
2002-07-23 |
2004-01-29 |
Smithkline Beecham Corporation |
Pyrazolopyrimidines as protein kinase inhibitors
|
AU2003261204A1
(en)
|
2002-07-23 |
2004-02-09 |
Smithkline Beecham Corporation |
Pyrazolopyrimidines as kinase inhibitors
|
JP2006514918A
(ja)
|
2002-07-23 |
2006-05-18 |
スミスクライン ビーチャム コーポレーション |
キナーゼインヒビターとしてのピラゾロピリミジン
|
US20060105445A1
(en)
|
2002-07-29 |
2006-05-18 |
Klaus Godl |
Medium and method for enriching, purifying or depleting atp binding proteins from a pool of proteins
|
US7241790B2
(en)
|
2002-07-30 |
2007-07-10 |
University Of Virginia Patent Foundation |
Compounds active in spinigosine 1-phosphate signaling
|
EP1539137B1
(en)
|
2002-07-30 |
2010-05-26 |
Merck Sharp & Dohme Corp. |
Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
|
AU2003256842B8
(en)
|
2002-07-30 |
2009-06-18 |
Merck Sharp & Dohme Corp. |
PPAR alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
|
JP2004067575A
(ja)
|
2002-08-06 |
2004-03-04 |
Yaizu Suisankagaku Industry Co Ltd |
糖尿病治療薬効果促進剤
|
PL376372A1
(pl)
|
2002-08-08 |
2005-12-27 |
Amgen Inc. |
Ligandy receptora waniloidowego oraz ich zastosowanie w leczeniu
|
DE10237722A1
(de)
|
2002-08-17 |
2004-08-19 |
Aventis Pharma Deutschland Gmbh |
Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase
|
EP1545540A2
(en)
|
2002-08-21 |
2005-06-29 |
Merck & Co., Inc. |
Combination therapy using a dual ppar alpha/gamma agonist and an angiotensin ii type i receptor antagonist
|
AU2003260085B2
(en)
|
2002-08-29 |
2008-09-11 |
Merck & Co., Inc. |
Indoles having anti-diabetic activity
|
BR0313825A
(pt)
|
2002-08-29 |
2005-07-12 |
Merck & Co Inc |
Composto, composição farmacêutica, método para tratar de diabete mellitus tipo 2 em um mamìfero, e, uso de composto
|
WO2004024943A1
(ja)
|
2002-09-11 |
2004-03-25 |
Yamanouchi Pharmaceutical Co., Ltd. |
インスリン含量増加剤スクリーニング方法
|
JP2006510597A
(ja)
|
2002-09-27 |
2006-03-30 |
メルク エンド カムパニー インコーポレーテッド |
置換ピリミジン類
|
US7067658B2
(en)
|
2002-09-30 |
2006-06-27 |
Bristol-Myers Squibb Company |
Pyridino and pyrimidino pyrazinones
|
WO2004033431A2
(en)
|
2002-10-04 |
2004-04-22 |
Arena Pharmaceuticals, Inc. |
Hydroxypyrazoles for use against metabolic-related disorders
|
AU2003284111A1
(en)
|
2002-10-09 |
2004-05-04 |
Genaissance Pharmaceuticals, Inc. |
Itgb3 gene haplotypes and atorvastatin dose effects on hdl cholesterol
|
JP2006504755A
(ja)
|
2002-10-15 |
2006-02-09 |
スミスクライン ビーチャム コーポレーション |
Gsk−3阻害薬としてのピリダジン化合物
|
US7129239B2
(en)
|
2002-10-28 |
2006-10-31 |
Pfizer Inc. |
Purine compounds and uses thereof
|
AU2003285007A1
(en)
|
2002-10-30 |
2004-06-07 |
Merck & Co., Inc. |
Kinase inhibitors
|
AU2003277576A1
(en)
|
2002-11-08 |
2004-06-07 |
Takeda Pharmaceutical Company Limited |
Receptor function controlling agent
|
US7098235B2
(en)
|
2002-11-14 |
2006-08-29 |
Bristol-Myers Squibb Co. |
Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds
|
US20040110241A1
(en)
|
2002-12-06 |
2004-06-10 |
Segal Mark S. |
Materials and methods for monitoring vascular endothelial function
|
AU2003299791A1
(en)
|
2002-12-20 |
2004-07-22 |
Bayer Pharmaceuticals Corporation |
Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
|
WO2004058174A2
(en)
|
2002-12-20 |
2004-07-15 |
Bayer Pharmaceuticals Corporation |
Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
|
EP1581509B1
(en)
|
2002-12-20 |
2011-01-19 |
Merck Sharp & Dohme Corp. |
1-(amino)indanes as edg receptor agonists
|
JO2397B1
(en)
|
2002-12-20 |
2007-06-17 |
ميرك شارب اند دوم كوربوريشن |
Terazol derivatives as beta-hydroxy steroid dihydrogenase-1 inhibitors
|
GB0230021D0
(en)
|
2002-12-23 |
2003-01-29 |
Syngenta Ltd |
Fungicides
|
GB0230020D0
(en)
|
2002-12-23 |
2003-01-29 |
Syngenta Ltd |
Fungicides
|
GEP20084540B
(en)
|
2003-01-14 |
2008-11-25 |
Arena Pharm Inc |
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
|
ATE359782T1
(de)
|
2003-01-16 |
2007-05-15 |
Sb Pharmco Inc |
Heteroaryl-substituierte pyrrol(2, 3- b)pyridin- derivate als crf-rezeptor-antagonisten
|
AU2004207444B2
(en)
|
2003-01-17 |
2008-07-31 |
Merck & Co., Inc. |
N-cyclohexylaminocarbonyl benzenesulfonamide derivatives
|
GB0301259D0
(en)
|
2003-01-20 |
2003-02-19 |
Novartis Ag |
Organic compounds
|
AU2004210697B2
(en)
|
2003-02-11 |
2007-10-18 |
Irm Llc |
Novel bicyclic compounds and compositions
|
TW200418829A
(en)
|
2003-02-14 |
2004-10-01 |
Avanir Pharmaceutics |
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
|
BRPI0407658A
(pt)
|
2003-02-18 |
2006-02-21 |
Kyorin Seiyaku Kk |
derivados de ácido aminofosfÈnico, seus sais e hidratos que atuam como moduladores de receptor de s1p e agente farmacêutico
|
WO2004076413A2
(en)
|
2003-02-24 |
2004-09-10 |
Arena Pharmaceuticals, Inc. |
Phenyl- and pyridylpiperidine-derivatives as modulators of glucose metabolism
|
JP2004269469A
(ja)
|
2003-03-12 |
2004-09-30 |
Yamanouchi Pharmaceut Co Ltd |
ピリミジン誘導体又はその塩
|
JP2004269468A
(ja)
|
2003-03-12 |
2004-09-30 |
Yamanouchi Pharmaceut Co Ltd |
ピリミジン誘導体又はその塩
|
CN1795177A
(zh)
|
2003-03-28 |
2006-06-28 |
辉瑞产品公司 |
作为治疗动脉粥样硬化和肥胖症的cetp抑制剂的 1 , 2 , 4 , -取代的1,2,3,4,-四氢-和1,2二氢-喹啉以及1, 2 , 3 , 4-四氢-喹喔啉衍生物
|
AU2004234067B2
(en)
|
2003-04-30 |
2008-02-28 |
Novartis Ag |
Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
|
US7329680B2
(en)
|
2003-04-30 |
2008-02-12 |
The Institute For Pharmaceutical Discovery, Llc |
Heterocycle substituted carboxylic acids
|
EP1622860B1
(en)
|
2003-04-30 |
2012-02-29 |
Novartis AG |
AMINO-PROPANOL DERIVATIVES AS SPHINGOSINE-1-PHOSPHATE RECEPTOR MODULATORs
|
TWI494102B
(zh)
|
2003-05-02 |
2015-08-01 |
Japan Tobacco Inc |
包含s-〔2(〔〔1-(2-乙基丁基)環己基〕羰基〕胺基)苯基〕2-甲基丙烷硫酯及hmg輔酶a還原酶抑制劑之組合
|
ATE475421T1
(de)
|
2003-05-06 |
2010-08-15 |
Ustav Ex Botan Akademie Ved Ce |
Pyrazoloä4,3-düpyrimidines, verfahren zur ihre herstellung und deren verwendung
|
SE0301368D0
(sv)
|
2003-05-09 |
2003-05-09 |
Astrazeneca Ab |
Chemical compounds
|
US7083933B1
(en)
|
2003-05-09 |
2006-08-01 |
Prosidion Limited |
Methods for identification of modulators of OSGPR116 activity
|
WO2004103279A2
(en)
|
2003-05-15 |
2004-12-02 |
Merck & Co., Inc. |
3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
|
WO2004104205A2
(en)
|
2003-05-16 |
2004-12-02 |
Merck & Co., Inc. |
Enzymatic preparation of chiral indole esters
|
WO2004113330A1
(en)
|
2003-05-19 |
2004-12-29 |
Irm Llc |
Immunosuppressant compounds and compositions
|
AR044402A1
(es)
|
2003-05-19 |
2005-09-14 |
Irm Llc |
Compuestos heterociclicos y su uso como inmunodepresores. composiciones farmaceuticas que los contienen.
|
US7060697B2
(en)
|
2003-05-19 |
2006-06-13 |
Irm Llc |
Immunosuppressant compounds and compositions
|
MY150088A
(en)
|
2003-05-19 |
2013-11-29 |
Irm Llc |
Immunosuppressant compounds and compositions
|
US6987118B2
(en)
|
2003-05-21 |
2006-01-17 |
Pfizer Inc. |
Tetrahydroisoquinoline derivatives as PPAR-alpha activators
|
EP1635773A2
(en)
|
2003-06-06 |
2006-03-22 |
Merck & Co., Inc. (a New Jersey corp.) |
Combination therapy for the treatment of hypertension
|
AU2003902882A0
(en)
|
2003-06-10 |
2003-06-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Piperidyl derivatives
|
GB0313612D0
(en)
|
2003-06-12 |
2003-07-16 |
Novartis Ag |
Organic compounds
|
AR045047A1
(es)
|
2003-07-11 |
2005-10-12 |
Arena Pharm Inc |
Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
|
KR20060056944A
(ko)
|
2003-07-14 |
2006-05-25 |
아레나 파마슈티칼스, 인크. |
대사 조절제로서 융합된 아릴 및 헤테로아릴 유도체 및이에 관련된 장애의 예방 또는 치료
|
WO2005012221A1
(ja)
|
2003-08-04 |
2005-02-10 |
Ono Pharmaceutical Co., Ltd. |
ジフェニルエーテル化合物、その製造方法および用途
|
MXPA06001759A
(es)
|
2003-08-15 |
2006-05-12 |
Novartis Ag |
2,4-pirimidinadiaminas utiles en el tratamiento de enfermedades neoplasticas, desordenes del sistema inmune e inflamatorios.
|
CN103193822A
(zh)
|
2003-08-28 |
2013-07-10 |
诺瓦提斯公司 |
氨基丙醇衍生物
|
CN1874991A
(zh)
|
2003-08-29 |
2006-12-06 |
小野药品工业株式会社 |
能够结合s1p受体的化合物及其药物用途
|
KR20110140139A
(ko)
|
2003-08-29 |
2011-12-30 |
오노 야꾸힝 고교 가부시키가이샤 |
S1p 수용체 결합능을 갖는 화합물 및 그 의약 용도
|
JP2007504230A
(ja)
|
2003-09-02 |
2007-03-01 |
メルク エンド カムパニー インコーポレーテッド |
ジペプチジルペプチダーゼ−iv阻害剤のリン酸塩の新規結晶性形態
|
WO2005023762A1
(en)
|
2003-09-04 |
2005-03-17 |
Abbott Laboratories |
Pyrrolidine-2-carbonitrile derivatives and their use as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
|
TW201127828A
(en)
|
2003-09-05 |
2011-08-16 |
Vertex Pharma |
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
|
US7732442B2
(en)
|
2003-09-05 |
2010-06-08 |
Ono Pharmaceutical Co., Ltd. |
Chemokine receptor antagonist and medical use thereof
|
EP1699777B1
(en)
|
2003-09-08 |
2012-12-12 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
JP2007513058A
(ja)
|
2003-09-08 |
2007-05-24 |
武田薬品工業株式会社 |
ジペプチジルぺプチダーゼ阻害剤
|
WO2005025554A2
(en)
|
2003-09-09 |
2005-03-24 |
Japan Tobacco Inc. |
Dipeptidyl peptidase iv inhibitor
|
WO2005030127A2
(en)
|
2003-09-23 |
2005-04-07 |
Merck & Co., Inc. |
Novel crystalline form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
|
CN1856307A
(zh)
|
2003-09-23 |
2006-11-01 |
默克公司 |
喹啉钾通道抑制剂
|
JP2007528872A
(ja)
|
2003-10-01 |
2007-10-18 |
メルク エンド カムパニー インコーポレーテッド |
S1p受容体アゴニストとしての3,5−アリール置換、ヘテロアリール置換またはシクロアルキル置換された1,2,4−オキサジアゾール化合物
|
WO2005033099A2
(en)
|
2003-10-03 |
2005-04-14 |
Glenmark Pharmaceuticals Ltd. |
Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
|
US20060089335A1
(en)
|
2003-10-14 |
2006-04-27 |
Guosong Liu |
Compositions and methods for enhancing cognitive function and synaptic plasticity
|
GB0324236D0
(en)
|
2003-10-16 |
2003-11-19 |
Astrazeneca Ab |
Chemical compounds
|
PE20050444A1
(es)
|
2003-10-31 |
2005-08-09 |
Takeda Pharmaceutical |
Compuestos de piridina como inhibidores de la peptidasa
|
WO2005041899A2
(en)
|
2003-11-03 |
2005-05-12 |
University Of Virginia Patent Foundation |
Orally available sphingosine 1-phosphate receptor agonists and antagonists
|
US7338951B2
(en)
|
2003-11-10 |
2008-03-04 |
Synta Pharmaceuticals Corp. |
Pyridine compounds
|
JPWO2005044780A1
(ja)
|
2003-11-10 |
2007-05-17 |
杏林製薬株式会社 |
アミノカルボン酸誘導体とその付加塩及びs1p受容体調節剤
|
EP1743676A1
(en)
|
2003-11-12 |
2007-01-17 |
Phenomix Corporation |
Heterocyclic boronic acid derivatives, dipeptidyl peptidase IV inhibitors
|
MY141220A
(en)
|
2003-11-17 |
2010-03-31 |
Astrazeneca Ab |
Pyrazole derivatives as inhibitors of receptor tyrosine kinases
|
WO2005058315A1
(en)
|
2003-12-12 |
2005-06-30 |
Ribapharm, Inc. |
Novel heterocyclic compounds as ikk2 inhibitors with anti-hbv activity
|
WO2005058849A1
(en)
|
2003-12-15 |
2005-06-30 |
Glenmark Pharmaceuticals Ltd. |
New dipeptidyl peptidase in inhibitors; process for their preparation and compositions containing them
|
EP1697333A4
(en)
|
2003-12-17 |
2009-07-08 |
Merck & Co Inc |
3,4-DISUSBSTITUTED PROPANOIC CARBOXYLATES AS S1P RECEPTOR AGONISTS (EDG)
|
GB0329498D0
(en)
|
2003-12-19 |
2004-01-28 |
Novartis Ag |
Organic compounds
|
TW200521108A
(en)
|
2003-12-19 |
2005-07-01 |
Ono Pharmaceutical Co |
Compounds having lysophosphatidic acid receptor(LPA)-antagonizing effect and their use
|
DE10360835A1
(de)
|
2003-12-23 |
2005-07-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Bicyclische Imidazolverbindungen, deren Herstellung und deren Verwendung als Arzneimittel
|
WO2005061489A1
(en)
|
2003-12-24 |
2005-07-07 |
Prosidion Limited |
Heterocyclic derivatives as gpcr receptor agonists
|
US20080227786A1
(en)
|
2004-01-16 |
2008-09-18 |
Ferlita Russell R |
Novel Crystalline Salts of a Dipeptidyl Peptidase-IV Inhibitor
|
GB0401332D0
(en)
|
2004-01-21 |
2004-02-25 |
Novartis Ag |
Organic compounds
|
WO2005075426A1
(en)
|
2004-02-03 |
2005-08-18 |
Glenmark Pharmaceuticals Ltd. |
Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
|
WO2005077938A1
(en)
|
2004-02-11 |
2005-08-25 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
TW200530236A
(en)
|
2004-02-23 |
2005-09-16 |
Chugai Pharmaceutical Co Ltd |
Heteroaryl phenylurea
|
TWI355934B
(en)
|
2004-02-24 |
2012-01-11 |
Sankyo Co |
Pharmaceutical composition for treatment or prophy
|
TW200538433A
(en)
|
2004-02-24 |
2005-12-01 |
Irm Llc |
Immunosuppressant compounds and compositiions
|
US7718704B2
(en)
|
2004-02-24 |
2010-05-18 |
Irm Llc |
Immunosuppressant compounds and compositions
|
JPWO2005085214A1
(ja)
|
2004-03-05 |
2008-01-17 |
萬有製薬株式会社 |
ジアリール置換複素5員環誘導体
|
GB0405289D0
(en)
|
2004-03-09 |
2004-04-21 |
Novartis Ag |
Organic compounds
|
GB0405933D0
(en)
|
2004-03-16 |
2004-04-21 |
Glaxo Group Ltd |
Compounds
|
EP1737820B1
(en)
|
2004-04-02 |
2008-01-16 |
Merck & Co., Inc. |
Asymmetric hydrogenation process useful for the preparation of cycloalkanoindole derivatives
|
US20070219234A1
(en)
|
2004-04-12 |
2007-09-20 |
Kiyoshi Oizumi |
Thienopyridine Derivatives
|
AU2005249380C1
(en)
|
2004-04-23 |
2012-09-20 |
Exelixis, Inc. |
Kinase modulators and methods of use
|
MXPA06014129A
(es)
|
2004-06-04 |
2007-03-07 |
Arena Pharm Inc |
Derivados de arilo y heteroarilo sustituidos como moduladores del metabolismo y profilaxis y tratamiento de trastornos relacionados con los mismos.
|
WO2005123677A1
(en)
*
|
2004-06-16 |
2005-12-29 |
Actelion Pharmaceuticals Ltd |
4-carbonyl substituted 1,1,2-trimethyl-1a,4,5,5a-tetrahydro-1h-4-aza-cyclopropa'a!pentalene derivatives as agonists for the g-protein-coupled receptor s1p1/edg1 and immunosuppressive agents
|
JP5315611B2
(ja)
|
2004-06-23 |
2013-10-16 |
小野薬品工業株式会社 |
S1p受容体結合能を有する化合物およびその用途
|
DK1772145T3
(da)
|
2004-07-16 |
2011-05-30 |
Kyorin Seiyaku Kk |
Fremgangsmåde til effektiv anvendelse af medicin og fremgangsmåde til forebyggelse af bivirkninger
|
JP2007284350A
(ja)
|
2004-07-27 |
2007-11-01 |
Takeda Chem Ind Ltd |
糖尿病治療剤
|
WO2006010379A1
(en)
|
2004-07-29 |
2006-02-02 |
Actelion Pharmaceuticals Ltd. |
Novel thiophene derivatives as immunosuppressive agents
|
TW200611687A
(en)
|
2004-07-29 |
2006-04-16 |
Sankyo Co |
Pharmaceutical compositions used for immunosuppressant
|
EP1798226A4
(en)
|
2004-08-04 |
2009-06-17 |
Taisho Pharmaceutical Co Ltd |
TRAIZOL DERIVATIVE
|
WO2006020951A1
(en)
|
2004-08-13 |
2006-02-23 |
Praecis Pharmaceuticals, Inc. |
Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
|
US20060223866A1
(en)
|
2004-08-13 |
2006-10-05 |
Praecis Pharmaceuticals, Inc. |
Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity
|
WO2006034446A2
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Pyridine derivatives for inhibiting human stearoyl-coa-desaturase
|
JP2008514611A
(ja)
|
2004-09-23 |
2008-05-08 |
ワイス |
C型肝炎ウイルスによる感染を処置するためのカルバゾールおよびシクロペンタインドールの誘導体
|
WO2006039325A2
(en)
|
2004-10-01 |
2006-04-13 |
Merck & Co., Inc. |
Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
EP1806347A4
(en)
|
2004-10-08 |
2009-07-01 |
Astellas Pharma Inc |
PYRIMIDINE DERIVATIVES FUSED WITH AN AROMATIC RING
|
CA2583947A1
(en)
|
2004-10-12 |
2006-04-20 |
Forbes Medi-Tech (Research) Inc. |
Compounds and methods of treating insulin resistance and cardiomyopathy
|
TW200621257A
(en)
|
2004-10-20 |
2006-07-01 |
Astellas Pharma Inc |
Pyrimidine derivative fused with nonaromatic ring
|
WO2006047195A2
(en)
|
2004-10-22 |
2006-05-04 |
Merck & Co., Inc. |
2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as s1p receptor agonists
|
PL1650186T3
(pl)
|
2004-10-22 |
2008-11-28 |
Bioprojet Soc Civ |
Nowe pochodne kwasów dikarboksylowych
|
AR051596A1
(es)
|
2004-10-26 |
2007-01-24 |
Irm Llc |
Compuestos heterociclicos condensados nitrogenados como inhibidores de la actividad del receptor canabinoide 1; composiciones farmaceuticas que los contienen y su empleo en la preparacion de medicamentos para el tratamiento de trastornos alimentarios
|
AU2005305083B2
(en)
|
2004-11-03 |
2012-02-02 |
Arena Pharmaceuticals, Inc. |
GPR41 and modulators thereof for the treatment of insulin-related disorders
|
GB0425035D0
(en)
|
2004-11-12 |
2004-12-15 |
Novartis Ag |
Organic compounds
|
US20060122222A1
(en)
|
2004-11-18 |
2006-06-08 |
The Institutes For Pharmaceutical Discovery, Llc |
Heterocycle substituted carboxylic acids
|
EP1829863A4
(en)
|
2004-11-26 |
2009-04-22 |
Takeda Pharmaceutical |
ARYLALCANOIC ACID DERIVATIVE
|
EP1817280A1
(en)
|
2004-12-03 |
2007-08-15 |
Teva Pharmaceutical Industries Ltd. |
Ezetimibe polymorphs
|
EP1827606A2
(en)
|
2004-12-06 |
2007-09-05 |
University Of Virginia Patent Foundation |
Aryl amide sphingosine 1-phosphate analogs
|
EP1857118A1
(en)
|
2004-12-13 |
2007-11-21 |
Daiichi Sankyo Company, Limited |
Medicinal composition for treating diabetes
|
EP1826197B1
(en)
|
2004-12-13 |
2012-01-18 |
Ono Pharmaceutical Co., Ltd. |
Aminocarboxylic acid derivative and medicinal use thereof
|
MX2007007553A
(es)
|
2004-12-24 |
2007-08-15 |
Prosidion Ltd |
Agonistas del receptor acoplado a proteina g (gpr116) y uso de los mismos para tratar obesidad y diabetes.
|
US8193359B2
(en)
|
2004-12-24 |
2012-06-05 |
Prosidion Limited |
G-protein coupled receptor agonists
|
GB0428514D0
(en)
|
2004-12-31 |
2005-02-09 |
Prosidion Ltd |
Compounds
|
MY148521A
(en)
|
2005-01-10 |
2013-04-30 |
Arena Pharm Inc |
Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
|
DOP2006000008A
(es)
|
2005-01-10 |
2006-08-31 |
Arena Pharm Inc |
Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
|
DOP2006000010A
(es)
|
2005-01-10 |
2006-07-31 |
Arena Pharm Inc |
Procedimiento para preparar eteres aromáticos
|
DOP2006000009A
(es)
|
2005-01-13 |
2006-08-15 |
Arena Pharm Inc |
Procedimiento para preparar eteres de pirazolo [3,4-d] pirimidina
|
US20080124384A1
(en)
|
2005-01-19 |
2008-05-29 |
Blum Charles A |
Heteroaryl Substituted Piperazinyl-Pyridine Analogues
|
WO2006079406A1
(en)
|
2005-01-25 |
2006-08-03 |
Merck Patent Gmbh |
Mesogenic compounds, liquid crystal medium and liquid crystal display
|
EP1685841A1
(en)
|
2005-01-31 |
2006-08-02 |
Bayer Health Care Aktiengesellschaft |
Prevention and treatment of thromboembolic disorders
|
EP1863463A1
(en)
|
2005-02-14 |
2007-12-12 |
University Of Virginia Patent Foundation |
Sphingosine 1-phosphate agonists comprising cycloalkanes and 5-membered heterocycles substitued by amino and phenyl groups
|
JP5063581B2
(ja)
|
2005-03-23 |
2012-10-31 |
アクテリオン ファーマシューティカルズ リミテッド |
新規チオフェン誘導体
|
AU2006226018B2
(en)
|
2005-03-23 |
2012-07-12 |
Idorsia Pharmaceuticals Ltd |
Hydrogenated benzo (C) thiophene derivatives as immunomodulators
|
US7605269B2
(en)
|
2005-03-23 |
2009-10-20 |
Actelion Pharmaceuticals Ltd. |
Thiophene derivatives as Sphingosine-1-phosphate-1 receptor agonists
|
JP2008545767A
(ja)
|
2005-06-08 |
2008-12-18 |
ノバルティス アクチエンゲゼルシャフト |
多環式オキサジアゾールまたはイソキサゾールおよびsip受容体リガンドとしてのそれらの使用
|
EP1902730A4
(en)
|
2005-06-09 |
2009-11-11 |
Banyu Pharma Co Ltd |
NPY Y2 AGONIST FOR USE AS A THERAPEUTIC AGENT AGAINST DIARRHEA-ASSOCIATED DISEASE
|
MX2007016505A
(es)
|
2005-06-24 |
2008-03-07 |
Actelion Pharmaceuticals Ltd |
Nuevos derivados de tiofeno.
|
TWI418350B
(zh)
|
2005-06-24 |
2013-12-11 |
Sankyo Co |
含有ppar調節劑之醫藥組成物的用途
|
AU2006264651A1
(en)
|
2005-06-30 |
2007-01-11 |
Prosidion Limited |
G-protein coupled receptor agonists
|
EP1899329B1
(en)
|
2005-07-01 |
2011-10-05 |
Irm Llc |
Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors
|
US20070060573A1
(en)
|
2005-08-10 |
2007-03-15 |
Lars Wortmann |
Acyltryptophanols
|
US20090221547A1
(en)
|
2005-08-23 |
2009-09-03 |
Irm Llc |
Immunosuppressant Compounds and Compositions
|
CA2619093A1
(en)
|
2005-09-16 |
2007-03-29 |
Arena Pharmaceuticals, Inc. |
Modulators of metabolism and the treatment of disorders related thereto
|
TW200745055A
(en)
|
2005-09-23 |
2007-12-16 |
Organon Nv |
4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives
|
JPWO2007037196A1
(ja)
|
2005-09-29 |
2009-04-09 |
山本化成株式会社 |
インドリン系化合物及びその製造方法
|
BRPI0617077A2
(pt)
|
2005-10-07 |
2015-01-06 |
Kyorin Seiyaku Kk |
Agente terapêutico para tratamento de doenças do fígado contendo 2-amina-1, 3-propanediol derivativo como ingrediente ativo, e método para tratamento de doenças do fígado
|
AR057894A1
(es)
|
2005-11-23 |
2007-12-26 |
Actelion Pharmaceuticals Ltd |
Derivados de tiofeno
|
CA2630714C
(en)
|
2005-11-23 |
2014-01-14 |
Epix Delaware, Inc. |
S1p receptor modulating compounds and use thereof
|
ZA200805192B
(en)
|
2005-12-29 |
2009-11-25 |
Lexicon Pharmaceuticals Inc |
Multicyclic amino acid derivatives and methods of their use
|
TWI404706B
(zh)
|
2006-01-11 |
2013-08-11 |
Actelion Pharmaceuticals Ltd |
新穎噻吩衍生物
|
TW200736234A
(en)
|
2006-01-17 |
2007-10-01 |
Astrazeneca Ab |
Chemical compounds
|
BRPI0621226A2
(pt)
|
2006-01-19 |
2012-07-10 |
Orchid Reseach Lab Ltd |
compostos heterociclos
|
CA2635124C
(en)
|
2006-01-24 |
2014-04-29 |
Actelion Pharmaceuticals Ltd |
Novel pyridine derivatives
|
GB0601744D0
(en)
|
2006-01-27 |
2006-03-08 |
Novartis Ag |
Organic compounds
|
TWI389683B
(zh)
|
2006-02-06 |
2013-03-21 |
Kyorin Seiyaku Kk |
A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient
|
WO2007092638A1
(en)
|
2006-02-09 |
2007-08-16 |
University Of Virginia Patent Foundation |
Bicyclic sphingosine 1-phosphate analogs
|
TW200806611A
(en)
|
2006-02-09 |
2008-02-01 |
Daiichi Seiyaku Co |
Novel amidopropionic acid derivatives and medicine containing the same
|
US20070191371A1
(en)
|
2006-02-14 |
2007-08-16 |
Kalypsys, Inc. |
Heterocyclic modulators of ppar
|
CN101460458A
(zh)
|
2006-02-15 |
2009-06-17 |
阿勒根公司 |
具有1-磷酸-鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚-3-羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
|
JP2009526863A
(ja)
|
2006-02-15 |
2009-07-23 |
アラーガン、インコーポレイテッド |
スフィンゴシン−1−リン酸(s1p)受容体アンタゴニスト生物学的活性を有するアリールまたはヘテロアリール基を持つインドール−3−カルボン酸アミド、エステル、チオアミドおよびチオールエステル化合物
|
WO2007098474A1
(en)
|
2006-02-21 |
2007-08-30 |
University Of Virginia Patent Foundation |
Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as s1p receptor agonists
|
US7649098B2
(en)
|
2006-02-24 |
2010-01-19 |
Lexicon Pharmaceuticals, Inc. |
Imidazole-based compounds, compositions comprising them and methods of their use
|
MX2008011615A
(es)
|
2006-03-14 |
2008-09-22 |
Amgen Inc |
Derivados de acidos carboxilicos biciclicos utiles para tratar trastornos metabolicos.
|
US7790707B2
(en)
|
2006-03-21 |
2010-09-07 |
Epix Pharmaceuticals Inc. |
S1P receptor modulating compounds and use thereof
|
JP2007262009A
(ja)
|
2006-03-29 |
2007-10-11 |
Dai Ichi Seiyaku Co Ltd |
ヘテロアリール低級カルボン酸誘導体
|
ES2453372T3
(es)
|
2006-04-03 |
2014-04-07 |
Astellas Pharma Inc. |
Derivados de oxadiazol como agonistas de S1P1
|
PE20071221A1
(es)
|
2006-04-11 |
2007-12-14 |
Arena Pharm Inc |
Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
|
ES2354390T3
(es)
|
2006-04-11 |
2011-03-14 |
Arena Pharmaceuticals, Inc. |
Procedimientos de uso del receptor gpr119 para identificar compuestos útiles para aumentar la masa ósea en un individuo.
|
GB0607389D0
(en)
|
2006-04-12 |
2006-05-24 |
Novartis Ag |
Organic compounds
|
WO2007129473A1
(ja)
|
2006-05-09 |
2007-11-15 |
Daiichi Sankyo Company, Limited |
二環性アリール誘導体
|
WO2007129745A1
(ja)
|
2006-05-09 |
2007-11-15 |
Daiichi Sankyo Company, Limited |
ヘテロアリールアミド低級カルボン酸誘導体
|
JP4383525B2
(ja)
|
2006-05-09 |
2009-12-16 |
ファイザー・プロダクツ・インク |
シクロアルキルアミノ酸誘導体およびその医薬組成物
|
TW200811140A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
TW200811147A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
EP2043744A2
(en)
|
2006-07-13 |
2009-04-08 |
SmithKline Beecham Corporation |
Chemical compounds
|
JP2009545597A
(ja)
|
2006-08-01 |
2009-12-24 |
プリーシス・ファーマシューティカルズ・インコーポレイテッド |
スフィンゴシン−1−ホスフェート受容体(slp)のアゴニスト
|
AR062156A1
(es)
|
2006-08-01 |
2008-10-22 |
Praecis Pharm Inc |
Compuestos agonistas y selectivos del receptor s1p-1
|
US20090318389A1
(en)
|
2006-08-04 |
2009-12-24 |
Praecis Pharmaceuticals Incorporated |
Agonists of the sphingosine-1 phosphate receptor
|
RS53080B
(en)
|
2006-08-08 |
2014-06-30 |
Kyorin Pharmaceutical Co. Ltd. |
AMINOPHOSPHORIC ACID ETHAR DERIVATIVE AND S1P RECEPTOR MODULATOR CONTAINING THE SAME AS THE ACTIVE INGREDIENT
|
JP2010501555A
(ja)
|
2006-08-24 |
2010-01-21 |
プリーシス・ファーマシューティカルズ・インコーポレイテッド |
S1p−1受容体アゴニスト
|
JP2009269819A
(ja)
|
2006-08-25 |
2009-11-19 |
Asahi Kasei Pharma Kk |
アミン化合物
|
WO2008025800A1
(en)
|
2006-08-30 |
2008-03-06 |
Biovitrum Ab (Publ) |
Pyrimidine compounds for treating gpr119 related disorders
|
JP2010504286A
(ja)
|
2006-09-07 |
2010-02-12 |
アラーガン インコーポレイテッド |
スフィンゴシン−1−リン酸(s1p)受容体アゴニスト及び/又はアンタゴニスト生物活性を有するヘテロ芳香族化合物
|
CL2007002593A1
(es)
|
2006-09-07 |
2008-06-13 |
Actelion Pharmaceuticals Ltd |
Compuestos derivados de 4-heteroaril-piridina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como rechazo de organos transplantados, sindromes autoinmunes y cancer.
|
TWI408139B
(zh)
|
2006-09-07 |
2013-09-11 |
Actelion Pharmaceuticals Ltd |
新穎噻吩衍生物
|
EP2081888A1
(en)
|
2006-09-08 |
2009-07-29 |
Novartis AG |
N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions
|
MX2009002915A
(es)
|
2006-09-21 |
2009-03-31 |
Actelion Pharmaceuticals Ltd |
Derivados de fenilo y su uso como inmunomoduladores.
|
CA2671749C
(en)
|
2006-12-06 |
2013-07-09 |
Smithkline Beecham Corporation |
Bicyclic compounds and uses as antidiabetics
|
JP2010513272A
(ja)
|
2006-12-14 |
2010-04-30 |
メルク エンド カムパニー インコーポレーテッド |
アシルビピペリジニル化合物、そのような化合物を含む組成物、及び治療方法
|
WO2008076356A1
(en)
|
2006-12-15 |
2008-06-26 |
Abbott Laboratories |
Novel oxadiazole compounds
|
GB0625648D0
(en)
|
2006-12-21 |
2007-01-31 |
Glaxo Group Ltd |
Compounds
|
CL2007003784A1
(es)
|
2006-12-21 |
2008-06-27 |
Abbott Lab |
Compuestos derivados de 1-amino-3-fenilciclopentano, que son agonistas o antagonistas de uno o mas receptores de la familia s1p; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar la esclerosis multiple, artritis reumato
|
JO2701B1
(en)
|
2006-12-21 |
2013-03-03 |
جلاكسو جروب ليميتد |
Vehicles
|
KR20090101307A
(ko)
|
2007-01-11 |
2009-09-24 |
알러간, 인코포레이티드 |
스핑고신-1-포스페이트(s1p) 수용체 길항제 생물학적 활성을 갖는 6-치환된 인돌-3-카르복실산 아미드 화합물
|
WO2008091967A1
(en)
|
2007-01-26 |
2008-07-31 |
Smithkline Beecham Corporation |
Chemical compounds
|
WO2008097819A2
(en)
|
2007-02-05 |
2008-08-14 |
Smithkline Beecham Corporation |
Chemical compounds
|
DK2125797T3
(da)
|
2007-03-16 |
2014-02-10 |
Actelion Pharmaceuticals Ltd |
Aminopyridinderivater som s1p1/edg1-receptoragonister
|
EP2121648A2
(en)
|
2007-03-21 |
2009-11-25 |
EPIX Pharmaceuticals, Inc. |
S1p receptor modulating compounds and use thereof
|
WO2008128832A1
(en)
|
2007-04-18 |
2008-10-30 |
Nicox S.A. |
Nitroderivatives of non-peptidic renin inhibitors for the treatment of cardiovascular, renal and chronic liver disease, inflammations and metabolic syndrome
|
DE602008005285D1
(de)
|
2007-04-19 |
2011-04-14 |
Glaxo Group Ltd |
Oxadiazolsubstituierte indazolderivate zur verwendung als sphingosin-1-phosphat (s1p) -agonisten
|
JP2010526145A
(ja)
|
2007-05-04 |
2010-07-29 |
ブリストル−マイヤーズ スクイブ カンパニー |
[6,6]および[6,7]−二環式gpr119gタンパク質結合受容体アゴニスト
|
EP2014653A1
(en)
|
2007-06-15 |
2009-01-14 |
Bioprojet |
Novel dicarboxylic acid derivatives as S1P1 receptor agonists
|
WO2009011850A2
(en)
|
2007-07-16 |
2009-01-22 |
Abbott Laboratories |
Novel therapeutic compounds
|
WO2009019506A1
(en)
|
2007-08-03 |
2009-02-12 |
Astrazeneca Ab |
Heterocyclyc sulfonamides having edg-1 antagonistic activity
|
US8399448B2
(en)
|
2007-08-08 |
2013-03-19 |
Merck Serono Sa |
6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosis
|
NZ583495A
(en)
|
2007-09-20 |
2011-11-25 |
Irm Llc |
Compounds and compositions as modulators of gpr119 activity
|
UY31468A1
(es)
|
2007-11-15 |
2009-07-17 |
|
Derivados bis-(sulfonilamino) en terapia 065
|
EP2225201A2
(en)
|
2007-11-28 |
2010-09-08 |
Synta Pharmaceuticals Corp. |
Polymorphs of n-malonyl-bis(n'-methyl-n'-thiobenzoylhydrazide)
|
AU2008338965A1
(en)
|
2007-12-18 |
2009-06-25 |
Arena Pharmaceuticals, Inc. |
Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
|
JP2011510073A
(ja)
|
2008-01-25 |
2011-03-31 |
アリーナ ファーマシューティカルズ, インコーポレイテッド |
S1P1アゴニストとして作用するジヒドロ−1H−ピロロ[1,2−a]インドール−1−イルカルボン酸誘導体
|
AR070398A1
(es)
|
2008-02-22 |
2010-03-31 |
Gruenenthal Chemie |
Derivados sustituidos de indol
|
US20110000153A1
(en)
|
2008-02-28 |
2011-01-06 |
Solar Roofing Systems, Inc. |
Photovoltaic Roofing Tile with Fire Suppression
|
CN104800208A
(zh)
|
2008-03-17 |
2015-07-29 |
埃科特莱茵药品有限公司 |
选择性s1p1受体激动剂的给药方案
|
EP2146210A1
(en)
|
2008-04-07 |
2010-01-20 |
Arena Pharmaceuticals, Inc. |
Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY
|
WO2009125434A2
(en)
|
2008-04-07 |
2009-10-15 |
Cadila Healthcare Limited |
Oxime derivatives
|
JP2011516557A
(ja)
|
2008-04-07 |
2011-05-26 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Gpr119活性のモジュレーターとしての化合物および組成物
|
DK2291080T3
(en)
|
2008-05-14 |
2015-12-07 |
Scripps Research Inst |
Novel modulator of sphingosinphosphatreceptorer
|
WO2009151621A1
(en)
|
2008-06-13 |
2009-12-17 |
Arena Pharmaceuticals, Inc. |
Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists
|
WO2009151626A1
(en)
|
2008-06-13 |
2009-12-17 |
Arena Pharmaceuticals, Inc. |
Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists
|
CN104311472B9
(zh)
*
|
2008-07-23 |
2020-03-17 |
艾尼纳制药公司 |
经取代的1,2,3,4-四氢环戊并[b]吲哚-3-基乙酸衍生物
|
SI2342205T1
(sl)
|
2008-08-27 |
2016-09-30 |
Arena Pharmaceuticals, Inc. |
Substituirani triciklični kislinski derivati kot agonisti S1P1 receptorja, uporabni v zdravljenju avtoimunskih in vnetnih obolenj
|
KR101660555B1
(ko)
|
2008-12-22 |
2016-09-27 |
노파르티스 아게 |
S1p 수용체 효능제의 투여 요법
|
ME03594B
(me)
|
2008-12-22 |
2020-07-20 |
Novartis Ag |
Režim doziranja agonista s1p receptora
|
WO2010075273A1
(en)
|
2008-12-23 |
2010-07-01 |
Schering Corporation |
Bicyclic heterocycle derivatives and methods of use thereof
|
AU2009330208A1
(en)
|
2008-12-23 |
2011-08-04 |
Merck Sharp & Dohme Corp. |
Bicyclic heterocycle derivatives and methods of use thereof
|
WO2010074271A1
(ja)
|
2008-12-26 |
2010-07-01 |
武田薬品工業株式会社 |
糖尿病治療剤
|
TW201031668A
(en)
|
2009-01-22 |
2010-09-01 |
Mitsubishi Tanabe Pharma Corp |
Novel pyrrolo[2,3-d] pyrimidine compound
|
CN102387704A
(zh)
|
2009-02-10 |
2012-03-21 |
雅培制药有限公司 |
S1p5受体的激动剂和拮抗剂,和其用法
|
WO2011005290A1
(en)
|
2009-06-23 |
2011-01-13 |
Arena Pharmaceuticals, Inc. |
Disubstituted oxadiazole derivatives useful in the treatment of autoimmune and inflammatory disorders
|
WO2011005295A1
(en)
|
2009-06-24 |
2011-01-13 |
Arena Pharmaceuticals, Inc. |
Modulators of the sphingosine-1-phosphate (s1p) receptor useful for the treatment of disorders related thereto
|
AR077642A1
(es)
|
2009-07-09 |
2011-09-14 |
Arena Pharm Inc |
Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
|
AR077638A1
(es)
|
2009-07-15 |
2011-09-14 |
Lilly Co Eli |
Compuesto de (metanosulfonil -piperidin )-( alcoxi-aril) -tetrahidro- piridina , composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para el tratamiento de diabetes u obesidad
|
WO2011030139A1
(en)
|
2009-09-11 |
2011-03-17 |
Astrazeneca Ab |
4- (pyrimidin-2-yl) -piperazine and 4- (pyrimidin-2-yl) -piperidine derivatives as gpr119 modulators
|
MX336881B
(es)
|
2009-10-29 |
2016-02-04 |
Bristol Myers Squibb Co |
Compuestos heterociclicos triciclicos.
|
US8299059B2
(en)
|
2009-10-30 |
2012-10-30 |
Eli Lilly And Company |
Crystalline compound and a process for its preparation
|
US8440693B2
(en)
|
2009-12-22 |
2013-05-14 |
Novartis Ag |
Substituted isoquinolinones and quinazolinones
|
ES2529562T3
(es)
|
2009-12-30 |
2015-02-23 |
Medichem, S.A. |
Un derivado de 1-(1H-1,2,4-triazol-1-il)butan-2-ol para uso farmacéutico, y el uso de un derivado de 1-(1H-1,2,4-triazol-1-il)butan-2-ol con forma cristalina sustancialmente indefinida para preparar dicho derivado de 1-(1H-1,2,4-triazol-1-il)butan-2-ol
|
WO2011094008A1
(en)
*
|
2010-01-27 |
2011-08-04 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
|
CN105503882B
(zh)
|
2010-03-03 |
2019-07-05 |
艾尼纳制药公司 |
制备s1p1受体调节剂及其晶体形式的方法
|
CA2795513A1
(en)
|
2010-04-06 |
2011-10-13 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
WO2012015758A2
(en)
|
2010-07-30 |
2012-02-02 |
Saint Louis University |
Methods of treating pain
|
CN103221410B
(zh)
|
2010-09-22 |
2017-09-15 |
艾尼纳制药公司 |
Gpr119受体调节剂和对与其相关的障碍的治疗
|
PL2672823T3
(pl)
|
2011-02-07 |
2017-02-28 |
Biogen Ma Inc. |
Czynniki modulujące działanie receptora s1p
|
US20140018371A1
(en)
|
2011-04-01 |
2014-01-16 |
Arena Pharmaceuticals, Inc. |
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
|
US20140066369A1
(en)
|
2011-04-19 |
2014-03-06 |
Arena Pharmaceuticals, Inc. |
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
|
WO2012145604A1
(en)
|
2011-04-22 |
2012-10-26 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
WO2012145603A1
(en)
|
2011-04-22 |
2012-10-26 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
WO2012170702A1
(en)
|
2011-06-08 |
2012-12-13 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
WO2013055910A1
(en)
|
2011-10-12 |
2013-04-18 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
EA201491460A1
(ru)
|
2012-02-03 |
2015-01-30 |
Тева Фармасьютикал Индастриз Лтд. |
ПРИМЕНЕНИЕ ЛАХИНИМОДА В ЛЕЧЕНИИ ПАЦИЕНТОВ С БОЛЕЗНЬЮ КРОНА, У КОТОРЫХ НЕ ЭФФЕКТИВНА ТЕРАПИЯ ПЕРВОЙ ЛИНИИ АНТИ-TNFα
|
US20160038506A1
(en)
|
2012-02-14 |
2016-02-11 |
Repros Therapeutics Inc. |
Selective Estrogen Receptor Modulators With Short Half-Lives and Uses Thereof
|
US8962888B2
(en)
|
2012-12-03 |
2015-02-24 |
Physical Sciences, Inc. |
Forming spherical crystal habit
|
JP5589110B1
(ja)
|
2013-03-08 |
2014-09-10 |
株式会社ポーラファルマ |
晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
|
NZ734220A
(en)
|
2015-01-06 |
2022-01-28 |
Arena Pharm Inc |
Methods of treating conditions related to the s1p1 receptor
|
IL285890B
(en)
|
2015-06-22 |
2022-07-01 |
Arena Pharm Inc |
Slate-free crystal of the arginine salt of (Ar)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-4,3,2,1-tetrahydro-cyclopent[b]indole-3-yl ) acetic acid
|
JP2020507611A
(ja)
*
|
2017-02-16 |
2020-03-12 |
アリーナ ファーマシューティカルズ, インコーポレイテッド |
原発性胆汁性胆管炎の治療のための化合物および方法
|
CA3053416A1
(en)
*
|
2017-02-16 |
2018-08-23 |
Arena Pharmaceuticals, Inc. |
Compounds and methods for treatment of inflammatory bowel disease with extra-intestinal manifestations
|
AU2019280822A1
(en)
|
2018-06-06 |
2021-01-07 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the S1P1 receptor
|
JP7265620B2
(ja)
|
2018-10-03 |
2023-04-26 |
アリーナ ファーマシューティカルズ, インコーポレイテッド |
強皮症の治療のための方法
|
EP3886841A1
(en)
|
2018-11-30 |
2021-10-06 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the s1p1 receptor
|
KR20210113298A
(ko)
|
2019-01-08 |
2021-09-15 |
아레나 파마슈티칼스, 인크. |
S1p₁ 수용체와 관련된 병태의 치료 방법
|